This study examined whether age-related IgG accumulation in the dermis contributes to skin inflammation and aging, using both mouse and human tissue models, including an experimental IgG administration model in young mice.
IgG accumulates in the dermis with age and drives dermal inflammation and atrophy; in young mice, exogenous IgG induced chemokine expression, macrophage and T cell infiltration, IL-12 production, IFN-γ release, and suppressed fibroblast collagen synthesis.
The study relies on mouse models and human tissue samples without a clinical intervention trial; causal directionality in humans is inferred rather than directly tested; downstream signaling targets are proposed mechanistically but not therapeutically validated.
IgG-driven macrophage and T cell activation may be a targetable upstream driver of skin inflammaging. Clinicians should watch for emerging therapies aimed at reducing dermal IgG accumulation or blocking its downstream immune signaling to slow skin aging.
